The New Normal: Next steps for payers in response to CMS regulatory changes to Medicare Advantage
Earlier this year, CMS finalized multiple rules that impact MAOs, with significant ramifications to procedures for RADV audits. Listen as A&M Healthcare Industry Group Managing Director, Jeff de Los Reyes and Christina Steiner, Senior Director, talk with Brian Stimson, Partner at McDermott Will & Emery, to discuss actions that plans should consider in advance of these changes.
|
Special thank you to Brian Stimson, Partner at McDermott Will & Emery, for joining us on this podcast. Brian Stimson is the former Acting General Counsel and Principal Deputy General Counsel (second-ranking lawyer) for the US Department of Health and Human Services (HHS) in Washington, DC. He represents health clients in litigations, arbitrations and government investigations nationwide. As part of his practice, Brian counsels clients on how to navigate disputes that present overlapping legal, regulatory, public policy and business considerations. His collaborative and pragmatic approach draws on his work as a high-level HHS official and a litigator. |
